Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Our study examines the hypothesis that in addition to sugar starch-type diet, a fat-protein meal elevates postprandial glycemia as well, and it should be included in calculated prandial insulin dose accordingly. The goal was to determine the impact of the inclusion of fat-protein nutrients in the general algorithm for the mealtime insulin dose calculator on 6-h postprandial glycemia. SUBJECTS AND METHODS: Of 26 screened type 1 diabetes patients using an insulin pump, 24 were randomly assigned to an experimental Group A and to a control Group B. Group A received dual-wave insulin boluses for their pizza dinner, consisting of 45 g/180 kcal of carbohydrates and 400 kcal from fat-protein where the insulin dose was calculated using the following algorithm: n Carbohydrate Units×ICR+n Fat-Protein Units×ICR/6 h (standard+extended insulin boluses), where ICR represents the insulin-to-carbohydrate ratio. For the control Group B, the algorithm used was n Carbohydrate Units×ICR. The glucose, C-peptide, and glucagon concentrations were evaluated before the meal and at 30, 60, 120, 240, and 360 min postprandial. RESULTS: There were no statistically significant differences involving patients' metabolic control, C-peptide, glucagon secretion, or duration of diabetes between Group A and B. In Group A the significant glucose increment occurred at 120-360 min, with its maximum at 240 min: 60.2 versus -3.0 mg/dL (P=0.04), respectively. There were no significant differences in glucagon and C-peptide concentrations postprandial. CONCLUSIONS: A mixed meal effectively elevates postprandial glycemia after 4-6 h. Dual-wave insulin bolus, in which insulin is calculated for both the carbohydrates and fat proteins, is effective in controlling postprandial glycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chase, H. P., Saib, S. Z., MacKenzie, T., Hansen, M. M., & Garg, S. K. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00685.x · Cited by 116
Pańkowska, E., Szypowska, A., Lipka, M., Szpotańska, M., Błazik, M., & Groele, L. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00471.x · Cited by 88
Self-citationHeinemann, L. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300631 · Cited by 40
Cited by
Bell, K. J., Smart, C. E., Steil, G. M., Brand-Miller, J. C., King, B., & Wolpert, H. A. (2015) · Diabetes Care · doi:10.2337/dc15-0100 · Cited by 390
Smart, C. E. M., Evans, M., O’Connell, S. M., McElduff, P., Lopez, P. E., Jones, T. W., Davis, E. A., & King, B. R. (2013) · Diabetes Care · doi:10.2337/dc13-1195 · Cited by 240
Bell, K. J., Toschi, E., Steil, G. M., & Wolpert, H. A. (2016) · Diabetes Care · doi:10.2337/dc15-2855 · Cited by 121
“(14) proposed the use of a fat-protein unit, but themethoddoes not make allowances for interindividual differences in the effects of dietary fat and protein and was associated with a high rate of hypoglycemia (;1 in every 3 subjects) (15,16).”
BackgroundPaterson, M. A., Smart, C. E. M., Lopez, P. E., McElduff, P., Attia, J., Morbey, C., & King, B. R. (2016) · Diabetic Medicine · doi:10.1111/dme.13011 · Cited by 111
Effects of advanced carbohydrate counting in patients with Type 1 diabetes: a systematic review
Schmidt, S., Schelde, B., & Nørgaard, K. (2014) · Diabetic Medicine · doi:10.1111/dme.12446 · Cited by 94
Bozzetto, L., Alderisio, A., Giorgini, M., Barone, F., Giacco, A., Riccardi, G., Rivellese, A. A., & Annuzzi, G. (2016) · Diabetes Care · doi:10.2337/dc15-2189 · Cited by 75
Katz, M. L., Mehta, S., Nansel, T., Quinn, H., Lipsky, L. M., & Laffel, L. M. B. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0389 · Cited by 65
Lopez, P. E., Evans, M., King, B. R., Jones, T. W., Bell, K., McElduff, P., Davis, E. A., & Smart, C. E. (2018) · Diabetic Medicine · doi:10.1111/dme.13703 · Cited by 36
Metwally, M., Cheung, T. O., Smith, R., & Bell, K. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108516 · Cited by 29
Piechowiak, K., Dżygało, K., & Szypowska, A. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12500 · Cited by 24
“Few previous studies have shown that insulin dosing based on carbohydrate plus fat/protein counting leads to lower postprandial glucose levels.(4,16) There is a lack of studies estimating the effect of additional insulin for high protein, low-fat meals containing carbohydrates.”
BackgroundHybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series
Daly, A., Hartnell, S., Boughton, C. K., & Evans, M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211035447 · Cited by 23
Al Balwi, R., Al Madani, W., & Al Ghamdi, A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13436 · Cited by 19
“Therefore, as recommended by Pankowska et al.39 measuring the blood glucose until 240 min postprandially and the use of a CGM at home are advisable.”
BackgroundInfluentialJabłońska, K., Molęda, P., Safranow, K., & Majkowska, L. (2018) · Diabetes Therapy · doi:10.1007/s13300-017-0364-2 · Cited by 9
“However, when the dose of insulin was increased for protein and fat content, significantly more episodes of hypoglycemia were observed [7, 11].”
BackgroundInfluential
Metadata
- Authors
- Pańkowska, E., Błazik, M., & Groele, L.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2012-01
- Volume
- 14
- Issue
- 1
- Pages
- 16-22
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2011411944
- Cited by
- 141
- References
- 3
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.